The company expects that this development could improve the strength of its application to the FDA for new drug approval
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Cipla has a robust governance model focused on sustainability
Subscribe To Our Newsletter & Stay Updated
